A Study of E7090 in Participants With Unresectable Advanced or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor (FGFR) 2 Gene Fusion
Clinical trial NCT04238715 · COMPLETED
Trial details
- NCT number
- NCT04238715
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-22
- Primary completion
- 2025-11-03
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.